Regent Technologies (REGT) Stock Price, News & Analysis

Company Overview

Regent Technologies, Inc. (OTCMKTS: REGT) is a specialized provider of quality control materials and assay solutions for clinical, environmental, and food diagnostic laboratories. The company develops, manufactures, and distributes a comprehensive portfolio of calibrators, controls, and proficiency testing materials designed to support immunoassay, molecular diagnostics, and chromatography-based testing platforms. By offering meticulously characterized reference materials, Regent Technologies enables laboratories to maintain regulatory compliance, ensure analytical accuracy, and streamline assay validation processes.

At the core of Regent Technologies’ product lineup are its Certified Reference Materials (CRMs), which are produced under rigorous quality management systems and conform to ISO 17034 standards. These materials span a wide range of analytes, including hormones, infectious disease markers, environmental contaminants, and foodborne pathogens. In addition to off-the-shelf offerings, the company provides custom assay development and contract manufacturing services, helping clients design bespoke reagent formulations and performance verification protocols tailored to specific instrumentation and testing requirements.

Founded in the late 1970s and headquartered in Kirkland, Washington, Regent Technologies has cultivated a global customer base that encompasses hospital networks, independent diagnostic laboratories, governmental agencies, and research institutions. The company maintains distribution partnerships across North America, Europe, Asia, and Latin America, ensuring timely delivery and local support. Over the decades, Regent Technologies has expanded its production capabilities and technical support infrastructure, reinforcing its reputation for reliability and responsiveness in the highly regulated diagnostics sector.

Under the leadership of President and Chief Executive Officer Dr. William H. Martin, Regent Technologies emphasizes ongoing investment in research and development, quality assurance, and regulatory compliance. The executive team, including Chief Scientific Officer Dr. Jennifer L. Li and Chief Operating Officer Gary Miller, focuses on enhancing product portfolios and forging strategic collaborations with assay developers and instrumentation manufacturers. This leadership commitment positions Regent Technologies to address emerging testing challenges and evolving industry standards while continuing to deliver robust quality control solutions to its global clientele.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

REGT Stock Analysis - Frequently Asked Questions

How do I buy shares of Regent Technologies?

Shares of REGT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Manufacturing
• Industry: Electronic Computer Manufacturing
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: OTCMKTS:REGT
• CIK: 319200
• Web: regent-tec.com
• Phone: +1-855-7447449
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A